IDI is in exclusive negotiations to sell its stake in Winncare

IDI has announced that it has entered into exclusive negotiations for the sale of its minority stake in the Winncare group, a specialist in medical devices for people with reduced autonomy. This transaction marks the end of IDI's involvement, which began in 2014 as the majority shareholder.

Winncare, under the leadership of Laurent Faugère, has seen its revenue increase from €45 million in 2014 to approximately €150 million in 2025, driven by strategic acquisitions and international expansion. The group's shareholders include Siparex ETI, Crédit Agricole, BNP Paribas Développement, and Kartesia.

The sale aims to strengthen Winncare's financial capacity to support its growth, focused on innovation and international development. The transaction requires approval from the relevant authorities and the works council.